Piramal Enterprises Ltd’s NCD Tranche I Issue to open October 19, 2023 | Coupon rate up to 9.35% p.a.#

• Public Issue of secured, rated, listed, redeemable, non-convertible debentures (NCDs) of face value of ₹ 1,000 each
• The Tranche I Issue of NCDs is for a Base Issue Size of ₹ 200 crores with a green shoe option of up to ₹ 800 crores aggregating up to ₹ 1,000 crores, (“Tranche I Issue”) which is within the shelf limit of Rs. 3,000 crores (“Shelf Limit”).
• NCDs are rated as [ICRA] AA (Stable) by ICRA Limited, and CARE AA; Stable by CARE Ratings Limited

• Coupon Rate up to 9.35% p.a^#
• Tranche I NCD Issue opens on Thursday, October 19, 2023, and closes on Thursday, November 2, 2023** with an option of early closure or extension
• The NCDs are proposed to be listed on BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”) (“the Stock Exchanges”). BSE is the Designated Stock Exchange for the Tranche I Issue
• Allotment on First come first serve basis***

 Piramal Enterprises Limited, is a non-deposit taking, RBI registered systemically important NBFC, engaged in providing wholesale and retail lending, has filed Tranche I prospectus dated October 16, 2023 to be read with the Shelf Prospectus dated October 16, 2023 (“Shelf Prospectus” together with the Tranche I Prospectus referred as the “Prospectus”) for public issue of secured, rated, listed, redeemable, non-convertible debentures of the face value of  ₹ 1,000 each. The base issue size is Rs. 200 crores with a green shoe option of up to Rs. 800 crores, aggregating up to  ₹ 1,000 crores (“Tranche I Issue”), which is within the shelf limit of  ₹ 3,000 crores (“Issue”).

The Tranche I Issue opens on Thursday, October 19, 2023, and closes on Thursday, November 2, 2023 with an option of early closure or extension in compliance with Securities and Exchange Board of India Issue and listing of (Non-Convertible Securities) Regulations 2021, as amended (“SEBI NCS Regulations”). The NCDs are proposed to be listed on BSE and NSE, with BSE being the Designated Stock Exchange for the Issue. The NCDs have been rated [ICRA] AA (Stable by ICRA Limited and CARE AA; Stable by CARE Ratings Limited.

The minimum application size is ₹ 10,000 (i.e. 10 NCDs) and thereafter in multiples of ₹ 1,000 (i.e. 1 NCD) thereof. The issue has maturity / tenure options of 2 years, 3 years, 5 years and 10 years for NCDs with annual coupon payment being offered across series I, II, III, and IV respectively. Effective yield for NCD holders in various categories ranges from 9.00% to 9.34% per annum.

Out of the net proceeds of the Tranche I Issue, at least 75% shall be utilised for the purpose of onward lending, financing and for repayment / prepayment of interest and principal of existing borrowings of the Company and a maximum up to 25% will be utilised for general corporate purposes.

The terms of each series of Secured NCDs, offered under Tranche I Issue are set out below:

* The Company shall allocate and allot Series II NCDs wherein the Applicants have not indicated the choice of the relevant NCD Series.

A. K. Capital Services Limited, JM Financial Limited, Nuvama Wealth Management Limited (formerly known as Edelweiss Securities Limited), and Trust Investment Advisors Private Limited are the lead managers to the Issue (“Lead Managers”). IDBI Trusteeship Services Limited is the Debenture Trustee to the Issue and Link Intime India Private Limited is the Registrar to the Issue.

About Piramal Enterprises Limited: Piramal Enterprises Limited is the flagship company of the Piramal Group, one of the leading conglomerates in India. The Company is a non-deposit taking, RBI registered systemically important NBFC, engaged in providing wholesale and retail lending. Its retail lending business is primarily conducted through its wholly owned subsidiary, Piramal Capital and Housing Finance Company Limited (“PCHFL”), a housing finance company registered with the National Housing Bank (“NHB”).

With an aim to segregate the businesses of the Piramal Group, the Company entered into a scheme of arrangement pursuant to which the pharma business was demerged from PEL and transferred under a separate listed entity – Piramal Pharma Limited (PPL). Further, PHL Fininvest Private Limited (PFPL), a wholly-owned subsidiary of PEL, was merged into PEL w.e.f. August 12, 2022.

PEL received the registration as a Non-Banking Financial Institution – Systemically Important Non-Deposit taking from RBI on July 26, 2022. Under the applicable RBI guidelines, PEL is identified as a Non-Banking Finance Company – Middle Layer (“NBFC-ML”), and its Subsidiary, PCHFL is identified as a Non-Banking Finance Company – Upper Layer “NBFC-UL”).

PEL presently provides (i) wholesale funding solutions to real estate developers, corporates and SMEs across sectors; and (ii) retail funding opportunities including housing finance, loan against property, secured small and medium enterprises (“MSMEs”) loans, other secured loans and unsecured loans (including microfinance loans) to individuals and MSMEs. In addition to wholesale and retail lending business, PEL also have a fund management business which provides customised funding solutions through Piramal Credit Fund. As of June 30, 2023, PEL has 424 conventional branches, including 136 microfinance branches across 25 states and union territories across India.

Capitalised terms not defined herein shall have the same meaning as assigned to such terms in the Prospectus.